Rationale: The ARDS Network (ARDSNet) used a positive end-expiratory pressure (PEEP)/FI O 2 model in many studies. In general, pediatric intensivists use less PEEP and higher FI O 2 than this model.
Although adequate positive end-expiratory pressure (PEEP) is essential to prevent atelectrauma in patients with acute respiratory distress syndrome (ARDS), observational data in both adults and children highlight that many patients with ARDS are on PEEP lower than recommended (1) (2) (3) . Although PEEP titration methods are controversial, previous ARDS studies have used a PEEP/FI O 2 titration table popularized by the ARDS Network (ARDSNet) (3) (4) (5) . This table recommends combinations of PEEP and FI O 2 , such that both are escalated or deescalated in tandem as hypoxemia worsens or improves. Although other approaches may have advantages, degree of hypoxemia is an important consideration in PEEP management (4, 6, 7) .
There is substantial variability in PEEP/FI O 2 combinations chosen during usual care ventilation, with a proclivity toward increasing FI O 2 over PEEP for hypoxemia (2, (8) (9) (10) (11) This issue becomes even more important in pediatrics, as there are virtually no studies examining the relationship between PEEP and mortality in ARDS, although several confirm the PEEP/FI O 2 table recommendations from ARDSNet are rarely followed in children (8, 9, (11) (12) (13) (14) . In general, there is reluctance to escalate PEEP above 10 cm H 2 O, particularly for younger children (8, 11) . Through secondary analysis of aggregated data from four previously published studies of children with pediatric ARDS (PARDS) (11, (15) (16) (17) (18) , we sought to determine if patients managed with PEEP levels lower than recommended by the ARDSNet table for a given FI O 2 in actual practice had higher mortality than patients who were managed with PEEP levels consistent with or higher than recommended by the ARDSNet table.
Methods
We combined four previously published datasets of invasively mechanically ventilated children with PARDS (15) (16) (17) (18) . Two of the datasets were gathered retrospectively by reviewing the electronic health records of pediatric ICU (PICU) patients admitted to Children's Hospital Los Angeles (CHLA) from 2000 to 2007 (15) and 2009 to 2013 (16) . One dataset was gathered prospectively from patients admitted to the Children's Hospital of Philadelphia (CHOP) from 2011 to 2016 (17, 18) . The fourth dataset was gathered prospectively across eight hospitals in the Collaborative Pediatric Critical Care Research Network (CPCCRN) from 2011 to 2012 (11) . We excluded CHOP and CHLA patients from the CPCCRN dataset to prevent any potential patient overlap. The parent studies were approved by their respective institutional review boards, and anonymous data were aggregated for this study.
PARDS Eligibility
Although inclusion criteria for each of the four studies differed slightly, we included patients who met the Pediatric Acute Lung Injury Consensus Conference definition of PARDS while on invasive mechanical ventilation (1) . Hypoxemia for the PARDS definition was based on oxygenation index (OI) greater than or equal to 4 or oxygen saturation index greater than or equal to 5. The CHLA dataset from 2000 to 2007 and the CHOP dataset included patients only on the basis of OI, whereas the CHLA dataset from 2009 to 2013 and the CPCCRN dataset included patients using oxygen saturation index when OI was not available. All patients had a PARDS trigger (i.e., pneumonia, sepsis), with pulmonary parenchymal disease on chest radiograph. Patients whose respiratory failure was believed to be primarily due to cardiac disease were excluded. Although required to meet Pediatric Acute Lung Injury Consensus Conference criteria for inclusion, because our question of interest focused on PEEP (which affects mean airway pressure in the OI calculation), we chose to group hypoxemia severity on the basis of the Berlin definition (Pa O 2 /FI O 2 [PF] ratio), imputing PF ratio from the ratio of oxygen saturation as measured by pulse oximetry to FI O 2 using previously published equations (19) when an arterial blood gas measurement was not available. We report PICU mortality as a function of PEEP discordance relative to the ARDSNet table. We next explored factors that may be associated with PICU mortality or PEEP lower than recommended by the protocol for a given FI O 2 . Continuous variables were analyzed against mortality with a Mann-Whitney U test, as data were often not normally distributed. Categorical data were analyzed with a chi-square test with Yates correction. ICU mortality was also examined as a function of PEEP lower than the protocol, with survival analysis, stratified by initial PF ratio. We then constructed a multivariate logistic regression model retaining variables that were either associated with PICU mortality or resulted in a greater than 15% change in the parameter estimates for PEEP lower than the protocol, also considering multiplicative interaction terms (retaining those with P , 0.1). Given the high correlation among many ventilator and hypoxemia variables, for multivariable models we used PF ratio (imputed from oxygen saturation as measured by pulse oximetry to FI O 2 ratio when Pa O 2 not available) instead of OI because of the overlap of mean airway pressure with PEEP and other ventilator settings. We selected other variables, which were highly correlated with one another on the basis of a correlation matrix (i.e., driving pressure and peak inspiratory pressure), retaining the variable with the highest univariate association with the outcome, to avoid issues of colinearity. Finally, a propensity score was created to model clinical and severity-of-illness factors associated with PEEP lower than the protocol, considering all variables with a univariate relationship (P , 0.2), retaining variables that maintained independent relationships with low PEEP (P , 0.1). This propensity score was used as covariate adjustment when further analyzing the independent relationship between PEEP lower than the protocol and PICU mortality. Analysis was performed using Microsoft Excel (Microsoft Corporation), Statistica version 12 (StatSoft), and Stata version 10 (StataCorp).
Sensitivity Analysis
We performed a sensitivity analysis stratifying by those with persistent hypoxemia (PF < 200) at 24 hours. In addition, because of notable differences between CHOP and CHLA datasets, we performed subgroup analyses within datasets and did comparative analyses between datasets. For the CHLA patients only, we examined whether the relationship was similar on Day 2 and 3 of mechanical ventilation. Additional subgroup analyses can be found in the online supplement. 
Results

Description of Cohort
PEEP Discordance
On unadjusted analysis, there was a dosedependent trend that patients managed with PEEP less than recommended by the protocol for a given FI O 2 for the first 24 hours of PARDS diagnosis had higher mortality, with the highest survival appearing to be with PEEP levels 1 to 4 cm H 2 O above what would be recommended by the protocol (Figure 2A) . When stratifying by initial PF ratio, this pattern was consistent, with the largest effect seen in those with PF ratio between 100 and 200 ( Figures 2B-2D) . Overall, patients managed with PEEP lower than recommended by the protocol experienced higher mortality (26.5% vs. 14.9%, P , 0.001). Although this trend was consistent among all initial PF ratio groups, it was only statistically significant in those with PF ratio between 100 and 200 (PF , 100, 31% vs. 26%, P = 0.3; PF 100-200, 22.6% vs. 11.8%, P = 0.004; PF 200-300, 17.1% vs. 12.3%, P = 0.4; Figures 3A-3D) .
Because higher FI O 2 relative to PEEP may be a reflection of disease severity or For definition of abbreviations, see Table 1 . Data are presented as median (interquartile range) or n (%). When a Pa O 2 metric was not available, PF was calculated from ratio of oxygen saturation measured by pulse oximetry to FI O 2 , and OI was calculated from OSI using previously published formulae (19) . A total of 1,047 patients had PEEP/FI O 2 data available for analysis. Race, ARDS triggers, and comorbidities were not available in the CPCCRN data, so the total number is reduced to 979. Some patients did not have available data 24 hours after PARDS diagnosis (died, extubated, or no PF ratio, OI, or OSI available), so the number is reduced to 974. Twenty-eight-day ventilator-free days defined as the number of days in the first 28 days after ARDS diagnosis in which the patient was alive and not on invasive mechanical ventilation. The percentages refer to the percent overall patients, high/on-protocol PEEP, or low PEEP with a given variable. P values are comparing the difference between two PEEP groups, among variables or groupings of variables (i.e., P , 0.001 for PARDS severity implies difference in PARDS severity categories between high/on-protocol PEEP and low PEEP without post hoc comparison of which groups are different). (Table 2 ).
Multivariable and Propensity Models
In general, more hypoxemic patients with higher severity of illness were more likely to be managed with lower PEEP relative to FI O 2 ( Table 3 ). There were two significant multiplicative interactions that were included (CHOP dataset 3 nitric oxide and inotrope 3 stem cell transplant). The interaction between CHOP dataset and PEEP in relation to the protocol was not significant (P = 0.4). In addition, we created a propensity model for using PEEP lower than recommended by the protocol. Similarly, after adjusting for this propensity to use lower PEEP and other covariates, we found that lower PEEP relative to FI O 2 proposed in the ARDSNet model was independently associated with higher mortality (OR, 2.0; 95% CI, 1.24-3.22) (see Tables E1-E3 in the online supplement).
Sensitivity Analysis
When limiting the analysis to only those who had PF ratio less than or equal to 200 24 hours after PARDS diagnosis, the multivariable OR was similar, although no longer statistically significant (OR, 1.64; 95% CI, 0.97-2.77; P = 0.06). There were notable differences among the datasets, which prompted us to perform subgroup analysis and directly compare CHOP and CHLA patients. CHLA had a higher percentage of patients with initial PF ratio less than 100 (33% CHLA vs. 23% CHOP, P , 0.001). PF ratio improved in a similar percentage of patients by 24 hours between datasets (36% CHLA vs. 39% CHOP, P = 0.4). By 24 hours into PARDS diagnosis, 14.6% of patients at CHLA had PF less than 100 compared with 6.6% at CHOP (P , 0.001). Patients at CHOP were more likely to be on inotropes and vasopressors or have pneumonia or aspiration. Patients at CHLA were more likely to have sepsis, immunodeficiency, and solid organ transplant (Table 4 , all P , 0.05; stratified by PF, Table E4 ).
Regarding ventilator management, CHOP used higher PEEP when FI O 2 was between 0.21 and 0.6 compared with CHLA ( Figures E1A-E1D ). PEEP at CHOP follows a near-normal distribution, whereas PEEP at CHLA has more variability ( Figure 4) . CHOP used PEEP lower than protocol only 12.4% of the time (79% PF , 100; 17.5% PF 100-200; 2.9% PF 200-300), compared with 40% at CHLA (63% PF , 100; 45.1% PF 100-200; 28.4% PF 200-300). As a result, patients with PF ratio greater than 100 24 hours after PARDS diagnosis at CHOP were on a higher mean airway pressure, higher PEEP, and had a higher OI, with similar or higher PF ratio. CHOP patients were more likely to be on inhaled nitric oxide (97% PF , 100; 51% PF 100-200; 20% PF 200-300) than CHLA patients (26% PF , 100; 10% PF 100-200; 5% PF 200-300). Driving pressure and VT were similar between CHOP and CHLA ( Figures 5 and E2 and Tables 4 and E4) .
Nonconventional ventilation (NCV) strategies were used in 24.7% of patients within the first 24 hours of PARDS diagnosis at CHOP, compared with 9.6% at CHLA (P , 0.001). The median OI at initiation of NCV was 20 (IQR, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] , with a median PEEP of 12 (IQR, 10-12) at CHOP compared with a median OI of 35 (IQR, 18-48) with a median PEEP of 14 (IQR, 10-15) at CHLA (both P , 0.01). Mortality was similar between those who did and did not receive NCV within the first 24 hours at CHOP (14.3% vs. 14.4%, P = 0.99), but those who received NCV within the first 24 hours at CHLA had much higher mortality (44% vs. 18.9%, P , 0.001). At 
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CHOP, the first NCV mode was airway pressure release ventilation in 12.9%, extracorporeal membrane oxygenation in 1.3%, high-frequency oscillatory ventilation in 43%, and high-frequency percussive ventilation in 43%. Highfrequency oscillatory ventilation was the first NCV mode used at CHLA in all patients. On a univariate basis in both institutions, PEEP lower than protocol on Day 1 was associated with higher mortality ( Figure E3 ). This relationship was retained in the CHLA cohort after controlling for potential confounding factors (OR, 2.09; 95% CI, 1.26-3.46; Table 5 ). However, after controlling for confounding factors in the CHOP dataset, PEEP lower than the protocol was not associated with mortality (OR, 0.87; 95% CI, 0.32-2.35; Table 6 ).
Day 2 and 3 PEEP data were available from the CHLA dataset, and the multivariable odds ratios were similar, although findings were not statistically significant, likely because of smaller sample size (Tables E5  and E6 ).
Discussion
Using the ARDSNet PEEP/FI O 2 protocol as a framework to analyze observational data from more than 1,100 patients with PARDS, we have found that patients managed with PEEP levels lower than recommended by the ARDSNet model for a given FI O 2 had higher mortality. This is consistent when stratifying by PF ratio and holds after controlling for confounding variables directly in multivariable modeling, as well as in propensity-based covariate adjustment. Although we chose to combine datasets for the primary analysis using interaction terms to account for differences among the institutions, notable differences in comorbidities and ventilator management between datasets prompted us to perform subgroup analysis stratified by institution, namely CHOP and CHLA. The sensitivity analysis highlights that the relationship between PEEP lower than the protocol and mortality is most relevant in the CHLA data. We believe this is for several reasons. 1) CHOP patients are generally managed with PEEP in line with or higher than recommended by the protocol. Only 12% of patients have PEEP levels lower than recommended by the protocol at CHOP, compared with 40% at CHLA and 40% in the CPCCRN dataset. This resulted in higher PEEP and mean airway pressure for a similar PF ratio. 2) PEEP use does not vary as much at CHOP as a function of hypoxemia severity. At CHOP, nearly all patients with PF ratio greater than 100 had PEEP above protocol, and nearly all patients with PF less than 100 had PEEP below protocol. These extremes (,20% of patients below protocol when PF . 100 and 20% on or above protocol when PF , 100) make it difficult to draw conclusions about PEEP management from the CHOP dataset alone, because using observational data to compare outcomes of patients who are managed with different PEEP/FI O 2 combinations is dependent on variability in PEEP level for a given FI O 2 . This variability was present in CHLA and CPCCRN datasets, but not at CHOP. 3) Patients at CHOP were three to four times more likely to receive inhaled nitric oxide than those at CHLA, which may also alter hypoxemia severity. 4) CHOP uses nearly three times more NCV in the first 24 hours than CHLA, with a median OI of 20 at initiation of NCV at CHOP, compared with 35 at CHLA. 5) CHOP primarily uses pressure-regulated volume control, whereas CHLA uses primarily pressure control, although VT and driving pressure were similar between datasets. 6) Finally, CHOP included only patients with bilateral infiltrates on chest imaging, whereas the other datasets included patients with unilateral or bilateral disease. We chose not to stratify analysis on the basis of chest imaging interpretation, because each dataset used different methods for gauging bilateral versus unilateral disease (i.e., radiologist, intensivist, multiple practitioners, and timing of the films). Future studies need to standardize these interpretations before we understand their relevance.
Overall mortality was lower at CHOP than CHLA. Part of this relates to different inclusion criteria and methods for screening for PARDS, different PARDS triggers, differences in comorbidities between datasets, and differences in adjuvant therapies, such as inhaled nitric oxide and inotropes and vasopressors. However, ventilator strategies between institutions were similar with respect to VT and driving pressure but were notably different with oxygenation strategies (particularly higher PEEP at CHOP for those with mild or moderate ARDS and sooner transition to alternative modes of ventilation rather than further escalating PEEP for severe ARDS). These data highlight a reality of multicenter practice and research, that ventilator management is institution and practitioner dependent in the absence of an agreed-on protocol. There are few validated pediatric protocols, making this an important area for research. PEEP management at CHOP is less variable than CHLA, with significantly fewer patients managed with PEEP lower than recommended by ARDSNet (12% vs. 40%). These findings may contribute to the mortality differences between datasets.
Our findings could have significant implications. As our data and previous investigations have highlighted (2, 8, 9, 11) , there is reluctance among pediatric intensivists to escalate PEEP in response to hypoxemia, preferentially increasing FI O 2 . On average, PEEP plateaus around 10 cm H 2 O, even with severe hypoxemia. The reasons are likely multifactorial and may relate to concerns about high PEEP levels in infants and neonates with low chest wall elastance, concerns about (3, 15, 20, (24) (25) (26) (27) . In our analysis, for patients with initially similar levels of hypoxemia, management with PEEP that is escalated in conjunction with FI O 2 is associated with lower mortality than those for whom FI O 2 is primarily increased. Interestingly we found this pattern most evident in those with moderate hypoxemia (PF, 100-200). Although one could speculate as to physiologic reasons for this finding, it likely relates to sample size and variability in PEEP management in this range. The range of PEEP (below, on protocol, and higher than protocol) is well represented in this subgroup, making it more possible to find a relationship. A large proportion of patients with PF less than 100 were managed with PEEP below the protocol, and many were transitioned to alternative modes of ventilation, making it difficult to draw conclusions in this group specifically.
However, our observational data cannot and should not imply a causal relationship that management on the basis of the ARDSNet PEEP/FI O 2 table for PARDS would result in improved mortality, although there is strong biological plausibility for this (6) . Moreover, there are many reasons to believe that the ARDSNet PEEP/FI O 2 table is suboptimal in PARDS, as a more individualized approach using transpulmonary pressure, lung compliance, dead space, or other methods have strong theoretical advantages (5, 6, (28) (29) (30) (31) (32) (33) (34) . Nevertheless, our data do highlight that there may be problems with usual care PEEP management in PARDS and that clinical trials in this area should be a priority for research. This is particularly important in light of the recent findings from the Alveolar Recruitment for ARDS Trial (ART), that adult patients with ARDS managed with lung recruitment and PEEP titration on the basis of respiratory system compliance had higher mortality than those managed with the ARDSNet PEEP/FI O 2 protocol (35) .
We are limited by the data available, and it may be that our findings reflect patient severity of illness or residual unmeasured confounding. Because of the nature of the ARDSNet PEEP/FI O 2 titration model, patients with very negative PEEP discordance values must be on high levels of FI O 2 . Indeed, the largest proportion of patients who were managed with lower PEEP relative to the amount of FI O 2 had severe hypoxemia. To mitigate these concerns, we performed a variety of stratified analyses as well as two methods for adjustment and multivariable modeling. Our findings held after multivariable and propensity covariate adjustment incorporating oxygenation metrics, PARDS triggers, comorbidities, inotropes and vasopressors, admission severity of illness, other ventilator settings, and inhaled nitric oxide. However, we did not have data on other potential confounders (i.e., other cointerventions like neuromuscular blockade, prone positioning, air leak syndrome or pneumothorax, etc.), and there is potential selection bias on the basis of individual practices for arterial line placement and potential differences on the basis of bilateral versus unilateral infiltrates. These limitations can likely only be overcome with a well-designed randomized control trial.
In conclusion, through secondary analysis of data from more than 1,100 patients with PARDS, we have found that patients managed with PEEP levels lower than recommended by the ARDSNet PEEP/FI O 2 model experienced higher mortality, even after covariate adjustment. Randomized controlled trials targeting PEEP management in PARDS are needed. n
